Small & Emerging Outsourced Manufacturing Activities
Source: Life Science Leader
By Industry Standard Research
To better understand the outsourcing practices used by respondents’ companies, ISR asked research participants to provide an estimate for each of the activities shown below. Respondents from small and emerging biopharma companies rely heavily on CMOs for manufacturing activities. On average, 65 percent or more of the manufacturing activities listed below are outsourced. Small molecule API is outsourced at the highest rate, with 83 percent outsourced on average, and roughly two-thirds of respondents indicated 81 to 100 percent of small molecule API manufacturing is outsourced.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more